Product Information

ALLOPURINOL 300 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.0567 per EA under NDC 69315029201. Its NADAC has been published 138 times since Nov 8, 2023.

The High Outlier badge above means this manufacturer's average price in the Allopurinol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ALLOPURINOL 300 MG TABLET

Allopurinol
$0.0567per EA
High Outlier

Strength

300 mg/1

NDC

69315029201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ALLOPURINOL

Approval Type

Generic (ANDA)

FDA Application

ANDA214443

On Market Since

5/1/2024

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for ALLOPURINOL 300 MG TABLET has been published 138 times since Nov 8, 2023, and over the history we have for it it has declined 20.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0567 per EA
All-time high$0.0776 (Feb 14, 2024)
All-time low$0.0552 (Apr 22, 2026)
52-week high$0.0674
52-week low$0.0552
Median price$0.0660
Average price$0.0657
Largest weekly change-17.0% (Nov 20, 2024)
Weeks tracked138
Tracking sinceNov 8, 2023

Price History

1W

0.0%

1M

+0.7%

3M

-0.5%

6M

-10.0%

1Y

-14.9%

3Y

N/A

5Y

N/A

All

-20.5%

Generic Alternatives

The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ALLOPURINOL 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Leading Pharma, LLC, is $0.0567 per EA (NDC 69315029201), effective Jun 24, 2026.

How has the price of ALLOPURINOL 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 20.5%. It has been tracked across 138 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?

Since Nov 8, 2023, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0552 (Apr 22, 2026) to a high of $0.0776 (Feb 14, 2024), with a median of $0.0660 per EA.

Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?

11 NADAC-published products share the same active ingredient, strength, and dosage form as ALLOPURINOL 300 MG TABLET, but none are currently priced below it.

Who manufactures ALLOPURINOL 300 MG TABLET?

ALLOPURINOL 300 MG TABLET (NDC 69315029201) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.